Gender Differences in Risks of Coronary Heart Disease and Stroke in Patients with Type 2 Diabetes Mellitus and Their Association with Metabolic Syndrome in China
Table 4
Gender-specific presence and OR of high CHD risk depending on the number of MS components.
CHD, (%)
OR (95% CI)
Stroke, (%)
OR (95% CI)
Men
1
62
16 (25.8%)
1.0
2 (3.2%)
1.0
2
231
121 (52.4%)
3.16 (1.69, 5.91)‡
33 (14.3%)
5.0 (1.2, 21.4)
3
235
126 (53.6%)
3.32 (1.78, 6.20)‡
43 (18.2%)
6.7 (1.6, 28.6)
4
182
114 (62.6%)
4.82 (2.53, 9.17)‡
27 (14.8%)
5.2 (1.2, 22.7)
5
86
51 (59.3%)
4.19 (2.05, 8.55)‡
10 (19.6%)
3.9 (0.833, 18.7)
Women
1
23
1 (4.3%)
1.0
1 (4.3%)
1.0
2
102
17 (16.7%)
4.40 (0.56, 34.9)
4 (3.9%)
0.9 (0.1, 8.4)
3
191
41 (21.5%)
6.01 (0.79, 45.9)
18 (9.4%)
2.3 (0.3, 18.0)
4
236
74 (31.4%)
10.0 (1.33, 76.0)
27 (11.3%)
2.8 (0.4, 21.9)
5
166
58 (34.9%)
11.8 (1.55, 89.9)
12 (7.2%)
1.7 (0.2, 13.8)
and ‡ compared to subjects with type 2 diabetes mellitus without other components of MS. The 10-year CHD and stroke risk were estimated using the UKPDS risk engine with individuals categorized as high risk (>20% risk). CHD: coronary heart disease; MS: metabolic syndrome; OR: odds ratio.
